Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes.

CONCLUSIONS: All bDMARDs showed higher ACR20 response rates and better HAQ-DI mean reduction compared to placebo. This meta-analysis highlights the variability of bDMARD efficacy on ACR50/70, PASI75/90 and enthesitis or dactylitis response rates. Head-to-head studies are needed to draw definitive conclusions on potential efficacy-related differences between bDMARDs in PsA. PMID: 31969228 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31969228?dopt=Abstract

Source: Clinical and Experimental Rheumatology - January 25, 2020 Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research